Navigation Links
CLAAD Recognizes SMART/Script as Top 5 Technology To Reduce Rx Abuse
Date:11/27/2012

WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The Center for Lawful Access and Abuse Deterrence (CLAAD) today honored Atlantic Pharmaceuticals' SMART/Script as one of its "Top 5 Technologies To Reduce Prescription Drug Abuse."

Still in investigational stages, the SMART/Script technology is intended to deliver immediate- and extended-release opioid medications in a tamper-resistant form. If a medication formulated with SMART/Script were crushed or chewed, the SMART/Script technology would potentially prevent or slow the release of the active ingredient.

"We are honored to have our SMART/Script formulation system recognized by CLAAD and Millennium Laboratories," said Anthony Soscia, President of Atlantic Pharmaceuticals. "We believe that utilization of the SMART/Script platform will have a meaningful impact on prescription drug abuse."

The Top 5 Technologies competition aims to increase awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.

Michael Barnes, spokesman for CLAAD, stated, "We support Atlantic Pharmaceuticals and other companies working to make medications less susceptible to abuse."

San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest.  Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.

"We are proud to recognize Atlantic Pharmaceuticals for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories. 

About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care.  CLAAD's National Prescription Drug Abuse Prevention Strategy identifies the adoption of new technologies as an essential component of prescription drug abuse prevention policy.  Visit claad.org, and follow @claad_coalition. 

About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety. 

About Atlantic Pharmaceuticals, Inc.
Atlantic Pharmaceuticals is a specialty pharmaceutical company developing technologies to increase the difficulty of tampering with orally administered immediate and sustained release pharmaceuticals. The company is using its proprietary SMART/Script (SMART/Simple, controllable, resistant, insoluble, physical trap) platform to formulate ATLP-02, a tamper resistant, immediate release, orally delivered oxycodone dosage form.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
2. CLAAD Names Eagle Advancement Institute as Honoree of Top 5 Technologies To Reduce Prescription Drug Abuse
3. CLAAD Warns of Increase in Prescription Drug Overdoses
4. MinuteClinic Recognizes National Nurse Practitioner Week and Invests in the Education and Advancement of Clinicians Across the U.S.
5. CareFusion Recognizes Best Of The Best U.S. Hospitals
6. Frost & Sullivan Recognizes Terso Solutions, Inc. with 2012 Best Practices Award
7. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
8. Frost & Sullivan Recognizes Secant Medical as a Key Technology Enabler for Medical Implantable Textile Structures Design
9. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
10. Veteran-Owned Wiley X,® Inc. Recognizes Americas Heroes
11. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 ... ... the Workers Compensation Research Institute (WCRI) officially opened registration today for its ... Place Hotel in Boston, MA . , The theme of the conference is ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital ... aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media ... Jr said, “CURE Media Group is honored to team up with Upstage Lung Cancer ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged ... in mind, SIGVARIS has created a new line of anti-embolism stockings to help ... provide the benefits of graduated compression when transitioning from recovery to early rehabilitation. ...
Breaking Medicine News(10 mins):